American Century Companies Inc. acquired a new position in shares of Elanco Animal Health (NASDAQ:ELAN) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 856,932 shares of the company’s stock, valued at approximately $29,898,000. American Century Companies Inc. owned 0.24% of Elanco Animal Health at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Rockefeller Capital Management L.P. purchased a new stake in shares of Elanco Animal Health in the third quarter valued at $274,000. FNY Investment Advisers LLC purchased a new position in shares of Elanco Animal Health in the 3rd quarter worth about $456,000. First Manhattan Co. purchased a new position in shares of Elanco Animal Health in the 3rd quarter worth about $348,000. Massachusetts Financial Services Co. MA purchased a new position in shares of Elanco Animal Health in the 3rd quarter worth about $48,580,000. Finally, Daiwa Securities Group Inc. purchased a new position in shares of Elanco Animal Health in the 3rd quarter worth about $425,000.

In other Elanco Animal Health news, Director Lawrence Erik Kurzius acquired 10,000 shares of Elanco Animal Health stock in a transaction dated Monday, September 24th. The stock was bought at an average cost of $24.00 per share, for a total transaction of $240,000.00. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Jeffrey N. Simmons acquired 22,000 shares of Elanco Animal Health stock in a transaction dated Monday, September 24th. The shares were acquired at an average price of $24.00 per share, with a total value of $528,000.00. The disclosure for this purchase can be found here. In the last quarter, insiders have acquired 33,000 shares of company stock valued at $792,000.

Shares of NASDAQ ELAN opened at $33.09 on Friday. Elanco Animal Health has a 52-week low of $30.10 and a 52-week high of $37.61.

Elanco Animal Health (NASDAQ:ELAN) last issued its earnings results on Tuesday, November 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.25 by $0.04. The company had revenue of $761.10 million during the quarter, compared to analyst estimates of $766.26 million. The business’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.14 earnings per share.

A number of equities analysts have recently commented on the company. BMO Capital Markets raised their price objective on Elanco Animal Health from $33.00 to $37.00 and gave the stock a “market perform” rating in a report on Tuesday. Credit Suisse Group initiated coverage on Elanco Animal Health in a research note on Monday, October 15th. They issued a “neutral” rating and a $36.00 target price for the company. Citigroup initiated coverage on Elanco Animal Health in a research note on Monday, October 15th. They issued a “buy” rating and a $37.00 target price for the company. Cowen initiated coverage on Elanco Animal Health in a research note on Monday, October 15th. They issued an “outperform” rating for the company. Finally, Bank of America initiated coverage on Elanco Animal Health in a research note on Monday, October 15th. They issued a “neutral” rating and a $34.00 target price for the company. Six equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $34.88.

COPYRIGHT VIOLATION NOTICE: This news story was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another domain, it was stolen and republished in violation of US and international trademark & copyright law. The original version of this news story can be accessed at https://www.thecerbatgem.com/2018/11/16/american-century-companies-inc-takes-position-in-elanco-animal-health-elan.html.

About Elanco Animal Health

There is no company description available for Elanco Animal Health Inc

Featured Article: What do investors mean by earnings per share?

Institutional Ownership by Quarter for Elanco Animal Health (NASDAQ:ELAN)

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.